What GLP-1 Does Medicare Cover for Diabetes?

If your doctor just said it's time to start a GLP-1 for type 2 diabetes, one question probably jumped the line ahead of all the others: what GLP-1 does Medicare cover for diabetes -- and what is this going to cost you?

Here's the straight answer. Medicare Part D -- the prescription-drug part of Medicare -- does cover GLP-1 medicines for type 2 diabetes. The ones most plans cover are Ozempic, Mounjaro, Rybelsus, Trulicity, and Victoza (or its lower-cost generic, liraglutide). What Medicare won't do is cover a GLP-1 for weight loss alone -- that's a completely separate program, and mixing the two up is the #1 reason people get confused or denied.

But there's a catch the insurance pages skip: "covered" doesn't mean automatic, and it doesn't mean cheap. Which drugs your specific plan covers -- and what you'll pay -- comes down to your plan's drug list and rules. Pick the wrong one and you're staring at a $1,000 pharmacy bill or a rejection at the counter. Get it right and you could pay $0 for part of the year.

Below is the full 2026 list, what you'll really pay, and the exact words to say to your plan so your request lands in the right lane instead of the reject pile. Let's start with which lane you're in.

Which GLP-1 does Medicare cover for diabetes in 2026?

For type 2 diabetes, Medicare Part D may cover the diabetes-labeled GLP-1s: Ozempic (pen or pill), Mounjaro, Rybelsus, Trulicity, and Victoza/generic liraglutide. No single plan covers all of them the same way -- each Medicare drug plan has its own list (called a formulary) and its own rules. So the real answer is "yes, but it depends on your plan."

The short list of what to ask about in 2026:

• Ozempic (semaglutide) -- weekly shot, or now a daily pill (Ozempic tablets)
• Mounjaro (tirzepatide) -- weekly shot
• Rybelsus (semaglutide) -- daily pill
• Trulicity (dulaglutide) -- weekly shot
• Victoza / generic liraglutide -- daily shot

The 2026 Medicare Diabetes GLP-1 Coverage Map

* Mounjaro is technically a "dual agonist" -- it works on two gut hormones (GIP and GLP-1), not just one -- but patients and plans treat it like the other GLP-1s. Covered = generally on Medicare drug-plan lists for type 2 diabetes. It is not a promise for your plan. Last verified June 17, 2026.

A quick note on the GLP-1s that are fading out

If an old article or forum post tells you to ask Medicare about Byetta or Bydureon BCise by brand name, slow down. AstraZeneca discontinued both brands in the U.S. in October 2024. The molecule isn't gone -- a generic exenatide (the same kind of twice-a-day injection as Byetta) launched in 2025 -- but a twice-daily shot is an older approach most people won't choose over the once-weekly drugs. Adlyxin is no longer sold here at all. In 2026, the practical list is Ozempic, Mounjaro, Rybelsus, Trulicity, and generic liraglutide.

Does Medicare cover Ozempic for diabetes?

Yes -- Medicare Part D may cover Ozempic when it's prescribed for type 2 diabetes and your plan lists it (or approves it through the plan's rules). It is not a guaranteed $0 and not an automatic approval. You still need to check three things: is it on your plan's list, what "tier" it's on (that sets your share of the cost), and whether your plan requires prior approval or step therapy.

Two quick definitions, because they decide everything:

• Prior authorization (PA) = your plan wants your doctor to prove the drug is medically necessary before it pays. For Ozempic, that usually means a documented type 2 diabetes diagnosis.
• Step therapy = your plan wants you to try a cheaper diabetes drug first (often metformin or another GLP-1) before it covers Ozempic.

Ozempic is FDA-approved for type 2 diabetes, and it's also approved to lower the risk of heart attack and stroke in certain adults with heart disease and to slow kidney disease -- which can matter for your approval if those conditions are in your chart. Without any insurance, the list price runs close to $1,000 a month, so coverage is the whole ballgame.

The fastest way to get a real answer is to call your plan and read this, word for word:

Write down what they say. That one call tells your doctor's office exactly how to send the prescription so it doesn't bounce.

Does Medicare cover Rybelsus or Ozempic tablets (oral semaglutide) for diabetes?

Yes -- Medicare Part D may cover oral semaglutide for type 2 diabetes, but check the exact product, because there are now two. Rybelsus is the original oral semaglutide pill (3, 7, or 14 mg). Ozempic now also comes as tablets (4 or 9 mg) -- Novo Nordisk describes the Ozempic pill as the only GLP-1 pill that lowers A1C and has a heart-benefit for high-risk adults with type 2 diabetes. Your plan may cover one and not the other, or place them on different tiers, so don't assume -- check the exact product name, form, and dose with your plan.

This is the section to read if your honest reaction to "weekly injection" is no thanks. A pill is needle-free -- but it isn't effort-free. Oral semaglutide has strict instructions (typically taken first thing in the morning on an empty stomach, with only a small sip of plain water, and nothing else for a set time), because that's what lets it absorb. Follow the exact directions for your specific pill, and let your doctor decide whether an oral option is appropriate for you -- it's not automatically the right choice for everyone.

Does Medicare cover Mounjaro for diabetes?

Yes -- Medicare Part D may cover Mounjaro for type 2 diabetes, and coverage is common: AARP, citing an Eli Lilly spokesperson, reports that more than 90% of commercial and Part D plans cover Mounjaro for people with type 2 diabetes. Like Ozempic, it usually needs prior approval, and some plans want you to try another GLP-1 first.

Mounjaro is FDA-approved to improve blood sugar in adults (and children 10 and older) with type 2 diabetes, used with diet and exercise. But "FDA-approved for diabetes" and "easiest to get covered by your plan" are not the same thing.

Why Mounjaro gets denied even when you have diabetes: the plan needs prior approval and it wasn't sent; the plan wants a preferred drug tried first (step therapy); the diagnosis wasn't documented clearly; the drug or dose isn't on your plan's list; or the pharmacy submitted it without the right information. Each one gives you a different next move -- see the denial section below.

Does Medicare cover Trulicity, Victoza, or generic liraglutide for diabetes?

Yes -- Medicare Part D may cover older diabetes GLP-1s like Trulicity, Victoza, or generic liraglutide. These matter most when your plan denies the newer drug and prefers one of these first. Trulicity is also approved to lower the risk of heart attack and stroke in certain adults, and Victoza is approved to lower heart-risk too.

Here's the insight most pages won't give you: the newest, most-advertised drug is often the hardest to get covered, and an older GLP-1 can be the faster, cheaper path. A few reasons:

• Your plan may require you to try a preferred GLP-1 before approving Ozempic or Mounjaro (that's step therapy).
• Generic liraglutide now exists, and a generic is usually on a lower, cheaper tier -- sometimes it's the very drug your plan wants you to try first.
• If you've already tried and didn't do well on one of these, that history can help your doctor get an exception so you can skip the step.

Important -- don't self-switch. We're not telling you to ask for Trulicity or liraglutide instead. We're telling you to ask your doctor one question: "If my plan won't cover the first drug, is a plan-preferred GLP-1 medically appropriate for me?" You make a better decision when the cost facts and the medical facts are on the table together.

Does the new $50 Medicare GLP-1 Bridge cover diabetes?

No -- not for diabetes. CMS is explicit: type 2 diabetes (along with sleep apnea and MASH) is covered through regular Part D, and people with those diagnoses are not eligible to get their GLP-1 through the Bridge. The Medicare GLP-1 Bridge is for weight loss only.

The Bridge is the program behind all the "$50 a month" headlines. Starting July 1, 2026 and running through December 31, 2027, eligible Medicare members with obesity can get a weight-loss GLP-1 for a flat $50/month copay. The covered drugs are Foundayo, Wegovy (shot and tablets), and Zepbound KwikPen only (not Zepbound vials or single-dose pens). It sits outside your regular Part D plan.

The thing nobody tells diabetics: your lane is usually the cheaper one

It feels backwards, so read this twice. For someone with diabetes, the regular Part D lane isn't just the only legal lane -- it's often the better deal over a full year.

Why? Every dollar you pay for a covered Part D drug counts toward your $2,100 yearly out-of-pocket limit. Once you hit that limit, your covered drugs cost $0 for the rest of the year. The Bridge's $50 copay does not count toward that limit -- so a Bridge user keeps paying $50 every single month, all year ($600 a year), while a Part D user can hit the cap in the first few months and then pay nothing.

So if you're searching the $50 program hoping it's your shortcut for diabetes: it isn't your door, and it probably wouldn't save you money anyway. Chase the Part D approval instead.

If you landed here wanting a GLP-1 for weight loss, not diabetes -- the Bridge probably is your door, and you may qualify with a BMI of 35+, or 30+ with conditions like heart failure or kidney disease, or 27+ with risks like prediabetes. We have a full walkthrough of who qualifies, how your doctor files it, and the $50 math in our Medicare GLP-1 Bridge guide.

What will you actually pay for a covered diabetes GLP-1 in 2026?

Your cost depends on your plan, the drug's tier, your deductible, and where you are in the year. In 2026, Medicare drug plans can charge a deductible of up to $615, then you pay a share (often about 25%) until your out-of-pocket spending on covered drugs hits $2,100 -- after that, covered drugs cost $0 for the rest of the year. Without coverage, GLP-1s run roughly $935-$1,100+ a month.

Here's how the year actually flows:

An illustrative example (not a plan quote -- your numbers will differ): say your plan has a $500 deductible and 25% coinsurance on a ~$950 drug. You'd pay the deductible, then about $237 a month -- and could reach the $2,100 cap in roughly three months, then pay $0 the rest of the year. That's the quiet upside of the covered lane: the cost front-loads, then stops.

Can't handle a big bill early in the year? Ask about the Medicare Prescription Payment Plan (sometimes called M3P). It lets you spread your out-of-pocket drug costs into smaller monthly payments across the year instead of paying it all at once at the pharmacy. It doesn't lower the total -- it smooths it out.

What's coming in 2027: Medicare negotiated a lower price for semaglutide (Ozempic and Rybelsus) of about $274 for a 30-day supply, down from a ~$959 list price -- effective January 1, 2027. One caution: that's the price Medicare pays the maker, not your guaranteed copay; your share still follows your plan's deductible, coinsurance, and the yearly cap.

Can you use an Ozempic or Mounjaro savings card with Medicare?

Almost always no. The "$25 a month" savings cards from Novo Nordisk (Ozempic) and Eli Lilly (Mounjaro) are for people with commercial insurance. They exclude anyone on Medicare, Medicaid, or other government coverage -- and it's not the drugmaker being stingy. Federal anti-kickback law prohibits manufacturer copay cards from being used on government-funded prescriptions. As the savings-card terms spell out, government beneficiaries are excluded -- there's no workaround.

• That $25 ad you saw? It's not available to you if you're on Medicare. Don't build your plan around it.
• A cash discount card (like the ones at the pharmacy counter) can sometimes beat your insurance price -- but money you pay that way usually won't count toward your $2,100 Part D cap. Ask before you bypass Medicare.
• For long-term affordability, a covered Part D approval almost always beats a one-off coupon -- because of that cap.

How to check if YOUR Medicare plan covers your GLP-1 (with scripts)

Check the exact drug, dose, and your diagnosis on your plan's drug list -- or on the Medicare Plan Finder at Medicare.gov -- before the prescription is sent. You need five facts: covered or not, the tier, prior authorization, step therapy, and quantity limits. A general "Medicare covers it" is not enough, because every plan's list is different.

The 5-step check:

1. Write down the exact drug, form, and dose (for example, "Ozempic 1 mg pen" or "Ozempic 9 mg tablet").
2. Confirm the prescription is for type 2 diabetes -- that's the covered reason.
3. Look it up on your plan's drug list or the Medicare Plan Finder at Medicare.gov.
4. Record the tier, and whether it needs prior authorization, step therapy, or has a quantity limit.
5. Have your doctor's office send the documentation before the pharmacy runs the claim again.

Call your plan and read this:

If the pharmacy already rejected it, call them and ask:

Those two questions turn a vague "denied" into a clear to-do list.

What documentation helps a Medicare prior authorization for diabetes?

A strong prior-authorization request proves the prescription is for a covered diagnosis and meets your plan's rules. That usually means your type 2 diabetes diagnosis, recent labs (like your A1C), your current and past diabetes medications, any reactions or reasons a cheaper drug won't work, and the exact drug and dose requested.

Here's the checklist to bring to your doctor:

• ✅ Type 2 diabetes diagnosis (documented in your chart, not just spoken)
• ✅ Recent A1C and relevant labs
• ✅ Current medications
• ✅ Diabetes medications you've already tried (with dates and how they went)
• ✅ Metformin history, if it applies
• ✅ Any reactions, side effects, or reasons a preferred drug isn't right for you
• ✅ Other conditions that support it (heart disease, kidney disease) -- if true
• ✅ The exact drug, dose, and form
• ✅ The pharmacy's rejection code or the plan's written denial reason, if you have it

What to do if Medicare denies your GLP-1 for diabetes

First, find the exact reason -- don't guess. A denial can mean the drug isn't on your list, prior approval was missing, step therapy wasn't done, the documentation was incomplete, the pharmacy billed it wrong, or the plan reviewed it as weight loss instead of diabetes. Each reason has a different fix.

If a fix doesn't work, you have the right to appeal -- and your odds go up when your doctor documents the diagnosis, A1C, and prior medications. You can also switch to a plan that covers your drug at a better tier during Medicare's open enrollment (October 15-December 7) -- for many people, that's the single biggest cost lever there is, because drug lists change every year. We walk through how providers handle prior authorization in our GLP-1 prior authorization guide.

When does an online provider make sense -- and the Medicare telehealth trap

An online (telehealth) provider can help if you don't have a doctor who'll prescribe, or you can't get an appointment for months. But here's the part most affiliate sites quietly skip -- and we'd rather you hear it from us:

For a covered diabetes GLP-1, your own primary-care doctor or endocrinologist is the best and cheapest path -- they can prescribe, document the diabetes diagnosis, and handle the prior authorization, all under your Part D coverage. Start there if they're responsive.

But if you don't have a prescriber, or your wait is months long, there's an honest middle path. A low-cost online visit through a marketplace like Sesame can get you evaluated (it has a track for type 2 diabetes), and the prescription gets sent to your own pharmacy -- where your Part D plan can cover the medication if it's on your formulary and the rules are met. The visit is cash-pay; the medication's coverage still depends on your plan, prior authorization, tier, and pharmacy network. It's an extra cost most people with a regular doctor won't need -- but for the prescriber gap, it beats waiting.

Who should skip the online-provider step: you already have a doctor handling the prior authorization; your denial is purely a drug-list issue and you just need to appeal; you're trying to use Medicare for compounded (non-FDA-approved) GLP-1s -- which isn't a Medicare-covered path; or you have urgent blood-sugar symptoms, in which case call your doctor or 911, not a website.

One more honest note: if you're not yet on Medicare -- say you're under 65 or in a transition -- a cash-pay service like Ro can be a legitimate option for FDA-approved medications. That's a different situation from the diabetes-on-Medicare reader this page is for. See our full Ro Body review if that's you.

What people actually get wrong about Medicare GLP-1 coverage

Most people who search this aren't asking "what is a GLP-1?" They already know. The questions underneath the search are sharper than that:

• "Is it being denied, or does it just need prior approval?"
• "Is it only covered if I have diabetes?"
• "Why does the news say Medicare covers these now -- but mine got rejected?"

That third one is the big one. The "$50 a month" headlines are about the weight-loss Bridge, not your diabetes prescription -- and the two run on totally different rules. Once you see that your diabetes GLP-1 goes through regular Part D (with its drug list, prior approval, and that helpful $2,100 cap), the whole thing stops feeling like a runaround. You're not being denied a benefit. You're just in a different lane than the headlines -- and yours is usually the cheaper one.

The questions above reflect patterns we see in real searches and public Medicare and GLP-1 discussions; we use them to understand what readers are confused about, not as medical or coverage evidence.

How we verified this guide

We built this page by separating three kinds of facts and treating each differently:

• Coverage facts (what Part D covers, the $50 Bridge, costs, the cap) come from CMS and Medicare.gov and major insurer policies.
• Drug facts (which GLP-1s are approved for diabetes, which were discontinued) come from FDA and manufacturer sources.
• Our recommendations (start with your own doctor; Sesame for the prescriber gap) are clearly labeled as our editorial take, based on those verified facts -- never a promise of coverage.

What still needs your check: your exact drug list, your tier, your copay, any prior-authorization or step-therapy rules, your preferred pharmacy, and whether your plan changed this year. Plug those in with the calls and scripts above.

Verification log: CMS Medicare GLP-1 Bridge pages, Medicare.gov Part D cost pages, Novo Nordisk Ozempic/Rybelsus pages, Eli Lilly Mounjaro pages, and Ro/Sesame policy pages were each checked on June 17, 2026.

About us, and our money: The RX Index is independent guidance for choosing your GLP-1 path. We score providers and treatment routes on what actually matters -- clinical legitimacy, care quality, transparency, access, and cost -- then help you decide where to start. We may earn a commission if you use certain provider links, like Sesame. That never changes our coverage answer. For a Medicare diabetes GLP-1, the first question is always your Part D lane, your drug list, and your doctor's documentation -- not which company pays us. Written by The RX Index Editorial Team. Last verified: June 17, 2026.

Frequently asked questions

What GLP-1 does Medicare cover for diabetes?

Medicare Part D may cover Ozempic (pen or pill), Mounjaro, Rybelsus, Trulicity, or Victoza/generic liraglutide for type 2 diabetes when the drug is on your plan's list or approved through your plan's rules. It does not cover GLP-1s for weight loss alone -- that's the separate $50 Medicare GLP-1 Bridge.

Does Medicare cover Ozempic for type 2 diabetes?

Yes. Medicare Part D may cover Ozempic for type 2 diabetes, usually with prior authorization. Check your plan's drug list and rules -- coverage and cost vary by plan. It is not covered for weight loss.

Does Medicare cover Ozempic tablets (the pill) for diabetes?

Medicare Part D may cover Ozempic tablets for type 2 diabetes if your plan lists the exact product and strength or approves it through plan rules. Because the pill is newer, don't assume that covering Rybelsus automatically means covering Ozempic tablets -- check the exact name and dose.

Does Medicare cover Mounjaro for diabetes?

Yes. Most Part D and Medicare Advantage drug plans cover Mounjaro for type 2 diabetes -- AARP, citing an Eli Lilly spokesperson, says more than 90% of plans do -- often with prior authorization. Mounjaro is the diabetes brand; Zepbound (same drug) is for weight loss and sleep apnea.

Does Medicare cover Rybelsus?

Yes. Medicare Part D may cover Rybelsus, the oral semaglutide pill, for type 2 diabetes; Novo Nordisk reports about 95% Part D coverage. Your plan still decides. Remember it must be taken on an empty stomach.

Does Medicare cover Trulicity for diabetes?

Yes. Medicare Part D may cover Trulicity for type 2 diabetes, depending on your plan's list and rules. It can also be a covered alternative if your plan denies a newer GLP-1.

Does Medicare cover Wegovy for diabetes?

Wegovy isn't the diabetes brand -- for diabetes, the semaglutide options are Ozempic and Rybelsus. Wegovy is covered by Part D only for heart-risk reduction in people with heart disease or for MASH (a liver condition), and it's in the $50 Bridge for weight loss -- not for diabetes.

Does Medicare cover Zepbound for diabetes?

No. Zepbound is the weight-loss/sleep-apnea brand. For diabetes, ask about Mounjaro (same active drug, tirzepatide, but the diabetes version). Part D may cover Zepbound for sleep apnea with obesity.

Is the $50 Medicare GLP-1 Bridge for people with diabetes?

No -- not for the diabetes diagnosis. CMS says type 2 diabetes is covered through regular Part D, and people with diabetes can't use the Bridge for it. The Bridge is for weight loss only (Wegovy, Zepbound KwikPen, Foundayo), starting July 2026.

Does the 2026 $2,100 out-of-pocket cap apply to GLP-1s?

Yes -- to GLP-1s your plan covers. Once your out-of-pocket spending on covered drugs reaches $2,100 in 2026, covered drugs cost $0 for the rest of the year. The cap does not apply to drugs your plan won't cover, and the Bridge's $50 copay doesn't count toward it.

Why was my Ozempic denied if I have diabetes?

Usually it's a missing prior authorization, an unmet step-therapy rule, incomplete documentation, the drug not being on your plan's list, a quantity limit, or the plan reading it as weight loss. Find the exact reason, then follow the denial steps -- each reason has a different fix.

Can Medicare cover a GLP-1 for prediabetes?

Generally not through regular Part D -- that needs a type 2 diabetes diagnosis. Prediabetes can be a qualifying condition for the weight-loss Bridge if you also have a BMI of 27 or higher. Ask your plan and prescriber before assuming coverage.

Can I use a manufacturer savings card with Medicare?

No. The $25 Ozempic and Mounjaro savings cards exclude people on Medicare, Medicaid, and other government coverage -- federal anti-kickback law prohibits it, and there's no workaround. Look at your Part D copay (and the Medicare Prescription Payment Plan) instead.

Is there a generic GLP-1 Medicare covers for diabetes?

Yes -- generic liraglutide is available and is often a lower-cost, plan-preferred option compared with brand-name Victoza. A generic exenatide (an older, twice-daily injection) also exists but is a niche choice. Ask your doctor what's appropriate for you.

Does Medicare Part B ever cover GLP-1s?

Not for the ones you give yourself (the shots and pills) -- those fall under the Part D drug benefit (or a Medicare Advantage plan that includes drug coverage), not Part B.

Sources

• CMS -- Medicare GLP-1 Bridge: Information for Medicare Beneficiaries and Information for Prescribers (eligible drugs Foundayo/Wegovy/Zepbound KwikPen; type 2 diabetes is Part D, ineligible for Bridge; BMI/condition criteria incl. prediabetes)
• KFF -- What to Know About the BALANCE Model and the Medicare GLP-1 Bridge (May 11, 2026); KFF Quick Take on the Bridge (Mar 2026) -- $50 copay, outside Part D, doesn't count toward the cap, $245 model net price
• Medicare.gov -- What do drug plans cover?, Drug plan rules, and How much does Medicare drug coverage cost? (formularies, tiers, 2026 deductible up to $615, $2,100 out-of-pocket cap); What's the Medicare Prescription Payment Plan?
• Wellcare -- Does Medicare Cover Weight-Loss Drugs? GLP-1 Coverage in 2026 (diabetes-covered list; PA/step therapy; $2,100 cap)
• Aetna Medicare -- Does Medicare Part D cover GLP-1 drugs like Ozempic? (diabetes-only coverage; ~$1,000 cash price)
• Humana -- Does Medicare Cover Ozempic? (Ozempic covered for diabetes, not weight loss)
• AARP -- Does Medicare Cover Ozempic / Weight-Loss Drugs? and Medicare 2027 Drug Price Negotiations List (Eli Lilly spokesperson: >90% of plans cover Mounjaro for T2D; $274 negotiated semaglutide price effective Jan 2027 vs ~$959 list)
• Fierce Pharma / Managed Healthcare Executive / Reuters -- IRA negotiated price $274/30-day for semaglutide, effective Jan 1, 2027
• Novo Nordisk -- Ozempic.com (Ozempic injection 0.5/1/2 mg and Ozempic tablets 4/9 mg for type 2 diabetes; Ozempic pill heart-benefit) and NovoMedLink Rybelsus cost & coverage (Novo reports ~95% Part D coverage)
• FDA labels / manufacturer sites -- Ozempic, Mounjaro, Rybelsus, Trulicity, Victoza indications
• Amneal / FDA / Drug Store News -- generic exenatide FDA-approved Nov 2024, launched 2025; brand Byetta and Bydureon BCise discontinued (U.S., Oct 2024); Adlyxin no longer marketed in the U.S.; generic liraglutide available
• Eli Lilly (Mounjaro) and Novo Nordisk (Ozempic) savings-card terms -- government beneficiaries excluded; HHS OIG and drugs.com -- manufacturer copay cards barred for Medicare by federal anti-kickback rules
• ro.co and U.S. News Ro Weight Loss Review -- Ro is cash-pay; can't coordinate GLP-1 coverage for most government plans (Medicare/Medicaid/TRICARE)
• sesamecare.com (/medication/semaglutide) -- type 2 diabetes track; prescription sent to your own pharmacy; medication coverage depends on your plan